
The report on " Cancer Immunotherapy Market by Application - (Breast, Prostate Melanoma, Colorectal, Head & Neck, Lung, and others), by Product Type – (Interferons, Therapeutic cancer vaccines, Monoclonal Antibodies, Adoptive T cell transfer, Checkpoint inhibitors/immune modulators, Oncolytic virus immunotherapy, Cytokines, Adjuvant Immunotherapy, Interleukins, BCG and others) by Mode of Administration – (Intravesical, Intravenous, Oral, Topical), by End users (Hospitals, Clinics) and by Region - Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)" is published by Market Data Forecast. The Global Cancer Immunotherapy Market was priced $ 62 Billion in 2016 and calculable to be growing at a CAGR of 12.40%, to achieve $ 111.23 Billion by 2021, within the mentioned forecast period. Smoking and excessive alcohol intake, are the principal reasons driving the demand for market growth. Other key factors attributing to the growth of the market are an increase in the occurrence of cancer among individuals. Fewer side effects related to cancer immunotherapy and reduced chances of reappearance of cancer are boosting the demand for market growth. However, when compared to other treatments, cancer immunotherapy is costly, and availability of less information is hindering the market growth.